Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
80
-
Total shares
-
31.4M
-
Shares change
-
+7.11M
-
Total reported value, excl. options
-
$106M
-
Value change
-
+$24.9M
-
Put/Call ratio
-
2.68
-
Number of buys
-
47
-
Number of sells
-
-33
-
Price
-
$3.38
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q4 2019
84 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q4 2019.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
.
Largest 10 shareholders include BlackRock Inc. (8.64M shares), VANGUARD GROUP INC (6.46M shares), Cormorant Asset Management, LP (4M shares), STATE STREET CORP (2.29M shares), GEODE CAPITAL MANAGEMENT, LLC (1.71M shares), NORTHERN TRUST CORP (1.58M shares), D. E. Shaw & Co., Inc. (576K shares), Nuveen Asset Management, LLC (497K shares), Rubric Capital Management LP (448K shares), and Bank of New York Mellon Corp (404K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.